Immunogenicity, safety, and tolerability of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young Japanese adults

Hepatitis B vaccines are highly effective in preventing hepatitis B virus infection and have been included in the national immunization program of Japan since 2016. Heptavax®-II is one of two hepatitis B vaccine products licensed in Japan, and its manufacturing process is being modified to reduce va...

Descripción completa

Detalles Bibliográficos
Autores principales: Kishino, Hiroyuki, Takahashi, Kenichi, Sawata, Miyuki, Tanaka, Yoshiyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067840/
https://www.ncbi.nlm.nih.gov/pubmed/29553862
http://dx.doi.org/10.1080/21645515.2018.1452578

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6067840/
https://www.ncbi.nlm.nih.gov/pubmed/29553862
http://dx.doi.org/10.1080/21645515.2018.1452578

Ejemplares similares